Metabolic Disorders After Liver Transplantation

Metabolic Disorders After Liver Transplantation

Early after surgery, liver transplant (LT) recipients often develop weight gain due to an increase of caloric intake and fat mass (without recovery of muscle frame). This modification of body composition together with a negative metabolic impact of immunosuppressive drugs leads to a high prevalence...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Metabolic syndrome and related disorders 2021-03, Vol.19 (2), p.65-69
Hauptverfasser: Gitto, Stefano, Falcini, Margherita, Marra, Fabio
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 69
container_issue 2
container_start_page 65
container_title Metabolic syndrome and related disorders
container_volume 19
creator Gitto, Stefano
Falcini, Margherita
Marra, Fabio
description Early after surgery, liver transplant (LT) recipients often develop weight gain due to an increase of caloric intake and fat mass (without recovery of muscle frame). This modification of body composition together with a negative metabolic impact of immunosuppressive drugs leads to a high prevalence of all the main metabolic disorders. Indeed, as expected, transplanted patients show a higher cardiovascular risk in comparison with general population. Notably, seeing the increase of mean age of transplanted population, metabolic disorders represent the true challenge for the transplant community. Considering the lack of evidences or clear indications about prevention, early diagnosis and treatment of metabolic disorders after LT, it would be mandatory to develop targeted further studies on this matter.
doi_str_mv 10.1089/met.2020.0068
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2454653068</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2454653068</sourcerecordid><originalsourceid>FETCH-LOGICAL-c293t-dcd7cf2ab23c6013fab8b1ba6620ed0bc8f7194626db4eb89680e4e2d3f042db3</originalsourceid><addsrcrecordid>eNo9kDlPAzEQRi0EIiFQ0qKUNJuMj3W8ZRROKYgm1JaPsbRoj2A7SPx7dpVAM98UT59mHiG3FBYUVLVsMS8YMFgASHVGprQsV4UqqTofdwGFoJWckKuUPgEYo1BekgnnFIQANSXLN8zG9k3t5g916qPHmObrkDHOt_X3MHfRdGnfmC6bXPfdNbkIpkl4c8oZ-Xh63G1eiu378-tmvS0cq3guvPMrF5ixjDsJlAdjlaXWSMkAPVinwopWQjLprUCrKqkABTLPAwjmLZ-R-2PvPvZfB0xZt3Vy2AyHYH9ImolSyJIPPw9ocURd7FOKGPQ-1q2JP5qCHh3pwZEeHWk48nen6oNt0f_Tf1L4L-XiYeU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2454653068</pqid></control><display><type>article</type><title>Metabolic Disorders After Liver Transplantation</title><source>Alma/SFX Local Collection</source><creator>Gitto, Stefano ; Falcini, Margherita ; Marra, Fabio</creator><creatorcontrib>Gitto, Stefano ; Falcini, Margherita ; Marra, Fabio ; MEDITRA Research Group ; the MEDITRA Research Group</creatorcontrib><description>Early after surgery, liver transplant (LT) recipients often develop weight gain due to an increase of caloric intake and fat mass (without recovery of muscle frame). This modification of body composition together with a negative metabolic impact of immunosuppressive drugs leads to a high prevalence of all the main metabolic disorders. Indeed, as expected, transplanted patients show a higher cardiovascular risk in comparison with general population. Notably, seeing the increase of mean age of transplanted population, metabolic disorders represent the true challenge for the transplant community. Considering the lack of evidences or clear indications about prevention, early diagnosis and treatment of metabolic disorders after LT, it would be mandatory to develop targeted further studies on this matter.</description><identifier>ISSN: 1540-4196</identifier><identifier>EISSN: 1557-8518</identifier><identifier>DOI: 10.1089/met.2020.0068</identifier><identifier>PMID: 33104408</identifier><language>eng</language><publisher>United States</publisher><ispartof>Metabolic syndrome and related disorders, 2021-03, Vol.19 (2), p.65-69</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c293t-dcd7cf2ab23c6013fab8b1ba6620ed0bc8f7194626db4eb89680e4e2d3f042db3</citedby><cites>FETCH-LOGICAL-c293t-dcd7cf2ab23c6013fab8b1ba6620ed0bc8f7194626db4eb89680e4e2d3f042db3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33104408$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gitto, Stefano</creatorcontrib><creatorcontrib>Falcini, Margherita</creatorcontrib><creatorcontrib>Marra, Fabio</creatorcontrib><creatorcontrib>MEDITRA Research Group</creatorcontrib><creatorcontrib>the MEDITRA Research Group</creatorcontrib><title>Metabolic Disorders After Liver Transplantation</title><title>Metabolic syndrome and related disorders</title><addtitle>Metab Syndr Relat Disord</addtitle><description>Early after surgery, liver transplant (LT) recipients often develop weight gain due to an increase of caloric intake and fat mass (without recovery of muscle frame). This modification of body composition together with a negative metabolic impact of immunosuppressive drugs leads to a high prevalence of all the main metabolic disorders. Indeed, as expected, transplanted patients show a higher cardiovascular risk in comparison with general population. Notably, seeing the increase of mean age of transplanted population, metabolic disorders represent the true challenge for the transplant community. Considering the lack of evidences or clear indications about prevention, early diagnosis and treatment of metabolic disorders after LT, it would be mandatory to develop targeted further studies on this matter.</description><issn>1540-4196</issn><issn>1557-8518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNo9kDlPAzEQRi0EIiFQ0qKUNJuMj3W8ZRROKYgm1JaPsbRoj2A7SPx7dpVAM98UT59mHiG3FBYUVLVsMS8YMFgASHVGprQsV4UqqTofdwGFoJWckKuUPgEYo1BekgnnFIQANSXLN8zG9k3t5g916qPHmObrkDHOt_X3MHfRdGnfmC6bXPfdNbkIpkl4c8oZ-Xh63G1eiu378-tmvS0cq3guvPMrF5ixjDsJlAdjlaXWSMkAPVinwopWQjLprUCrKqkABTLPAwjmLZ-R-2PvPvZfB0xZt3Vy2AyHYH9ImolSyJIPPw9ocURd7FOKGPQ-1q2JP5qCHh3pwZEeHWk48nen6oNt0f_Tf1L4L-XiYeU</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Gitto, Stefano</creator><creator>Falcini, Margherita</creator><creator>Marra, Fabio</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202103</creationdate><title>Metabolic Disorders After Liver Transplantation</title><author>Gitto, Stefano ; Falcini, Margherita ; Marra, Fabio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c293t-dcd7cf2ab23c6013fab8b1ba6620ed0bc8f7194626db4eb89680e4e2d3f042db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gitto, Stefano</creatorcontrib><creatorcontrib>Falcini, Margherita</creatorcontrib><creatorcontrib>Marra, Fabio</creatorcontrib><creatorcontrib>MEDITRA Research Group</creatorcontrib><creatorcontrib>the MEDITRA Research Group</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Metabolic syndrome and related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gitto, Stefano</au><au>Falcini, Margherita</au><au>Marra, Fabio</au><aucorp>MEDITRA Research Group</aucorp><aucorp>the MEDITRA Research Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic Disorders After Liver Transplantation</atitle><jtitle>Metabolic syndrome and related disorders</jtitle><addtitle>Metab Syndr Relat Disord</addtitle><date>2021-03</date><risdate>2021</risdate><volume>19</volume><issue>2</issue><spage>65</spage><epage>69</epage><pages>65-69</pages><issn>1540-4196</issn><eissn>1557-8518</eissn><abstract>Early after surgery, liver transplant (LT) recipients often develop weight gain due to an increase of caloric intake and fat mass (without recovery of muscle frame). This modification of body composition together with a negative metabolic impact of immunosuppressive drugs leads to a high prevalence of all the main metabolic disorders. Indeed, as expected, transplanted patients show a higher cardiovascular risk in comparison with general population. Notably, seeing the increase of mean age of transplanted population, metabolic disorders represent the true challenge for the transplant community. Considering the lack of evidences or clear indications about prevention, early diagnosis and treatment of metabolic disorders after LT, it would be mandatory to develop targeted further studies on this matter.</abstract><cop>United States</cop><pmid>33104408</pmid><doi>10.1089/met.2020.0068</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1540-4196
ispartof Metabolic syndrome and related disorders, 2021-03, Vol.19 (2), p.65-69
issn 1540-4196
1557-8518
language eng
recordid cdi_proquest_miscellaneous_2454653068
source Alma/SFX Local Collection
title Metabolic Disorders After Liver Transplantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T13%3A07%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20Disorders%20After%20Liver%20Transplantation&rft.jtitle=Metabolic%20syndrome%20and%20related%20disorders&rft.au=Gitto,%20Stefano&rft.aucorp=MEDITRA%20Research%20Group&rft.date=2021-03&rft.volume=19&rft.issue=2&rft.spage=65&rft.epage=69&rft.pages=65-69&rft.issn=1540-4196&rft.eissn=1557-8518&rft_id=info:doi/10.1089/met.2020.0068&rft_dat=%3Cproquest_cross%3E2454653068%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2454653068&rft_id=info:pmid/33104408&rfr_iscdi=true